Take Action

Newsroom

Filter By:
“Congress Must Fix Drug Discount Program Serving Poor, Uninsured”
October 30, 2017
Desert Sun
“Loopholes in 340B Drug Discount Program Need Fixes”
October 28, 2017
The Salt Lake Tribune
“Drug Discount Program not Working”
October 22, 2017
Tribune-Star
“Drug Program Needs Reforming”
October 11, 2017
Tribune-Star
AIR340B Coalition Releases New Report on DSH Hospitals’ Declining Charity Care Rates

Today, the AIR340B Coalition released a report, which found evidence that disproportionate share hospitals (DSH) participating in the 340B drug discount program often are not using the program as originally intended. The report comes a day before the House Energy & Commerce Subcommittee on Oversight and Investigations holds a hearing to investigate how providers utilize revenue generated by the 340B drug discount program.

October 10, 2017
“The 340B Program: Mandatory Reporting, Alternative Eligibility Criteria Should be Top Priorities for Congress”
October 10, 2017
Health Affairs
“Reforming the 340B Program Will Lower the Price of Prescription Drugs”
October 10, 2017
Forbes
In Case You Missed It: New Report Finds Cancer Treatment in Hospitals More Expensive Than in Community Practice Settings

The Community Oncology Alliance (COA) released a report last week on the costs of cancer treatment depending on the site of care. The report found that across various types of cancer profiles, the cost of cancer care for patients treated in the community clinic setting is about $8,000 less expensive per month than treatment in the hospital-based setting.* Looked at another way, the total cost of care for cancer patients receiving chemotherapy delivered in the hospital outpatient setting is nearly 60 percent, or $90,144, per year more expensive than the same treatment delivered in independent, community oncology practices.

October 2, 2017